4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-19-000055
CHIEF EXECUTIVE OFFICER acquired 25,375 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Singh Shawn CHIEF EXECUTIVE OFFICER | 2019-01-14 | Option exercise | +21,250 | $1.50 | $31,875 | 21,250 | D |
| Singh Shawn CHIEF EXECUTIVE OFFICER | 2019-01-14 | Option exercise | +1,125 | $1.50 | $1,688 | 22,375 | D |
| Singh Shawn CHIEF EXECUTIVE OFFICER | 2019-01-14 | Option exercise | +3,000 | $1.50 | $4,500 | 25,375 | D |
| Derivatives | |||||||
| Singh Shawn CHIEF EXECUTIVE OFFICER | 2019-01-14 | Option exercise · Stock Option (Right to Buy) | −21,250 | 0 | D | ||
| Singh Shawn CHIEF EXECUTIVE OFFICER | 2019-01-14 | Option exercise · Stock Option (Right to Buy) | −1,125 | 0 | D | ||
| Singh Shawn CHIEF EXECUTIVE OFFICER | 2019-01-14 | Option exercise · Stock Option (Right to Buy) | −3,000 | 0 | D | ||
Loading xslF345X03/form4-01152019_010122.xml…